Wassim Abida, Rahul Raj Aggarwal, Ivan de Kouchkovsky, Joshua Michael Lang, Jose De La Cerda, Hannah Dzimitrowicz McManus, Andrew J. Armstrong, Neal D. Shore, Alexander Z. Wei, Mark N. Stein, Marijo Bilusic, Geraldine Helen O'Sullivan Coyne, Fuat Bicer, Amir Mortazavi, Elisabeth I. Heath, Miriam Barnett, J. Erin Flynt, Vinidhra Sridharan, Jason Redman, David R. Wise. "Phase 1, dose-escalation study of KTX-2001 (an NSD2 inhibitor) alone and in combination with darolutamide for metastatic castration-resistant prostate cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps276